Company intelligence / Profile preview

Vistel

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Vistel has developed and commercialized the EyeWisdom Ophthalmology Diagnostic System, an AI-powered platform for screening and diagnosing over 10 fundus lesions and more than 20 eye disease risks. The system is widely recognized in China with high specificity (>93%) and is used by more than 500 medical clients. It supports early detection of major blinding eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration.

Therapeutic areas: Ophthalmology
Modalities: DeviceSoftwareArtificial intelligence-based diagnostic system (AI/ML-powered medical software)
Industry: Medical Imaging

Partnerships

Intel (technology partnership for AI hardware/software integration)Collaborations with leading Chinese hospitals including Peking Union Medical College Hospital, Beijing Tongren Hospital, Henan Provincial Eye Hospital, Peking University Third Hospital

Beyond the preview

Go deeper on Vistel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vistel.

Explore the full profile